Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02141503 · ClinicalTrials.gov registry record
Clinical Biomarkers in Alpha-mannosidosis
A clinical trial, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
- Completed
- Registry status
- 11
- Enrollment target
NCT02141503 is a clinical trial that has completed, run by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The registered enrollment target is 11 participants.
The verdict
NCT02141503 has completed, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
- COMPLETED
- Registry status
- 11 participants
- Enrollment target
Study Summary
Background: \- Alpha-mannosidosis is a rare inherited disorder. It causes problems in many organs and tissues of the body. It can occur in children and adults. Because there is no treatment for this disease, researchers want to find out more about it. Objective: \- To learn more about Alpha-mannosidosis. Eligibility: \- People ages 5-60 with Alpha-mannosidosis. Design: * Participants will be recruited from patient support organizations and medical genetics clinics. * Participants will have 3 study visits, about once a year. A final evaluation will be made after 3 years. * Participants will have a medical history and a physical exam. * Blood samples and a urine sample will be collected. * Cerebrospinal fluid will be collected. A small area of the lower back will be numbed with medicine. A thin needle will be inserted between the spine bones. About 2 tablespoons of spinal fluid will be removed. * Brain magnetic resonance spectroscopy (MRS) scans will be done at each visit. MRS uses a strong magnetic field and radio waves to take pictures of chemicals in the brain with a scanner. The participant will lie on a table that can slide in and out of the cylinder. While in the scanner the participant will hear loud knocking noises. They will get earplugs or earmuffs to muffle the sound. Medicines might be used to keep the participant asleep during the MRS. * Participants will have a skin biopsy at the first visit only. A small area of the participant s skin will be numbed. A small circle of skin will be removed with a biopsy tool.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2014-07-24 |
| Est. Completion | 2019-11-29 |
Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)305 total trials
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02141503
The ClinicalTrials.gov registry entry for NCT02141503 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has 305 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02141503 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02141503 about?
NCT02141503 is a clinical study titled "Clinical Biomarkers in Alpha-mannosidosis". Background: \- Alpha-mannosidosis is a rare inherited disorder. It causes problems in many organs and tissues of the body. It can occur in children and adults. Because there is no treatment for this disease, researchers want to find out more about it. Objective: \- To learn more about Alpha-manno...
What is the current status of trial NCT02141503?
This trial is currently completed. The enrollment target is 11 participants. The study started on 2014-07-24. Estimated completion is 2019-11-29.
Who is sponsoring clinical trial NCT02141503?
This trial is sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has 305 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.